New award for prasugrel tablets with golden state medical supply, INC. Ordering period is march 28, 2025 to march 27, 2026 with four one-year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0013
- Awardee
-
Golden State Medical Supply, Inc. UEI GQLDJJ8AQNN5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles Pre-Solicitation · 36E79724R0024 · Posted Sep 3, 2024
- Last date to order 100% complete
- IDV ceiling
- $2,445,241.70
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract by the VA National Acquisition Center for the supply of Prasugrel Hydrochloride tablets in 5 milligram and 10 milligram formulations, packaged in 30-count bottles. The contract, effective March 28, 2025, through March 27, 2026, with four one-year renewal options, carries a ceiling value of $2,445,241.70 and is designated for unrestricted competition with no set-aside provisions. The pharmaceutical supply will serve multiple federal healthcare systems, including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Based on the original solicitation requirements, the estimated annual demand includes 80,262 bottles of 10-milligram tablets and 4,724 bottles of 5-milligram tablets, with all products requiring the contractor's unique National Drug Code label and unit-of-use packaging equipped with safety-cap mechanisms compliant with federal specifications.
Prasugrel is a thienopyridine P2Y12 platelet inhibitor indicated for acute coronary syndrome management, representing a critical pharmaceutical supply requirement for federal healthcare beneficiaries requiring antiplatelet therapy. This contract replaces the previous national contract 36E79725D0013, which was terminated effective December 1, 2025, ensuring continuity of supply for this essential cardiovascular medication across the federal healthcare system. The contract structure—utilizing an indefinite delivery vehicle with a one-year base period and four option periods—provides both the government and contractor with supply flexibility while maintaining competitive pricing benchmarks established through the original request for proposal process issued in September 2024.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0013?
36E79725D0013 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on March 28, 2025.
How much is contract 36E79725D0013 worth?
36E79725D0013's own ceiling is $2,445,242.
Who can order from contract 36E79725D0013?
36E79725D0013 is a single award indefinite delivery contract.
Was contract 36E79725D0013 competed?
The extent of competition for 36E79725D0013 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV